Matrix metalloproteinases 3 polymorphism increases the risk of developing advanced endometriosis and infertility: A case-control study
article
OA: gold
CC0
⤵ 13 in-corpus citations
Abstract
Endometriosis has a complex and multifactorial pathology, and it is considered one of the main causes of infertility nowadays. The angiogenic process, which involves remodeling of extracellular matrix, is crucial for the development of this disease, mainly by the action of the matrix metalloproteinase 3 (MMP-3). It is known that genetic factors can influence endometriosis, thus; we investigated the role of MMP3 276G>A polymorphism as a risk factor for the development of the disease and its symptoms. This case-control study included 283 women with endometriosis (cases) and 217 women without the disease (controls) who were submitted to laparoscopic or laparotomy surgery. Real-time polymerase chain reaction performed by TaqMan system was applied for all polymorphisms. A multivariate logistic regression was performed to evaluate the association between polymorphism and endometriosis or clinical and gynecological characteristics of the disease, using their respective odds ratios (OR) and 95% confidence intervals (CI). The allelic frequency of the MMP3 276 G > A polymorphism was 33.6% in controls and 40.3% in endometriosis cases. The allelic distribution was significantly different between the two (P = 0.03). The variant genotype of MMP3 276AA was associated with increased endometriosis risk in the advanced endometriosis cases (OR: 2.08, 95% CI: 1.05 – 4.07 and OR: 1.87, 95% CI: 1.01 – 3.45). Regarding the symptoms, endometriosis-related infertile women had a positive association with the presence of MMP3 276 G > A polymorphism (OR: 3.13, 95% CI: 1.08–9.08 and OR: 3.30, 95% CI: 1.31 – 8.33). These findings suggest that the MMP3 276A polymorphism is involved with advanced endometriosis cases and infertility, and these associations may implicate in the behavior of disease.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Developmental origins of endometriosis: a Swedish cohort study via openalex
- Economic burden of deep infiltrating endometriosis of the bowel and the bladder in Germany: The statutory health insurance perspective via openalex
- Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis via openalex
- Endometriosis and Infertility via openalex
- Endometriosis and ovarian cancer: A review via openalex
- Endometriosis and ovarian cancer: A review via openalex
- Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members via openalex
- Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis via openalex
- Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases via openalex
- Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference via openalex
- Insights into Assessing the Genetics of Endometriosis via openalex
- Matrix Metalloproteinases and Endometriosis via openalex
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- Role of vascular endothelial growth factor polymorphisms (-2578C > A, -460 T > C, -1154G > A, +405G > C and +936C > T) in endometriosis: a case–control study with Brazilians via openalex
- W2025021247 via openalex
- W2074796887 via openalex
- W2127532993 via openalex
- W2016431623 via openalex
- W2005143522 via openalex
- W1988456342 via openalex
- W2542453300 via openalex
- W1986075242 via openalex
- W2770879766 via openalex
- W6646562587 via openalex
- W6728932704 via openalex
- W2031891599 via openalex
- W6757704270 via openalex
- W2064258819 via openalex
Cited by (13)
- Association of <i>MMP7</i> (−181A > G) promoter polymorphism with endometriosis in Eastern Indian women 2025
- An overview of endometriosis and molecular target-based therapeutic approach 2025
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- (no title) 2023
- Altered differentiation of endometrial mesenchymal stromal fibroblasts is associated with endometriosis susceptibility 2022
- Whole-exome sequencing and functional validation reveal a rare missense variant in <i>MMP7</i> that confers ovarian endometriosis risk 2022
- O PAPEL DOS POLIMORFISMOS GENÉTICOS NA ETIOLOGIA DA ENDOMETRIOSE 2022
- Altered Differentiation of Endometrial Mesenchymal Stromal Fibroblasts Is Associated With Endometriosis Susceptibility 2021
- The immune system and endometriosis 2021
- ADAMS-1 and ADAMS-9, novel markers in endometriosis 2021
- Investigating the association of matrix metalloproteinase-2 gene variants with endometriosis in an Iranian population 2020
- Matrix Metalloproteinases as Biomarkers of Endometriosis and the Role of Progesterone Receptors 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:35.348889+00:00
License: CC0
· commercial use OK